drugset / Trial / NCT04970940

The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

NCT04970940

Phase 1 Completed 30 enrolled AJU Pharm Co., Ltd.
RandomizedSingle-groupOpen-labelTreatment

Summary

To evaluate a pharmacokinetic drug interaction between AJU-A51R1 and AJU-A51R2 in healthy male volunteers.

Timeline

Start
2020-07-02
Primary completion
2020-10-07
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Forxiga Unknown
Subject Linagliptin Small molecule